HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carboxyl-terminal modulator protein facilitates tumor metastasis in triple-negative breast cancer.

Abstract
Currently, the survival rate for breast cancer is more than 90%, but once the cancer cells metastasize to distal organs, the survival rate is dramatically reduced, to less than 30%. Triple-negative breast cancer accounts for 15-20% of all breast cancers. Triple-negative breast cancer (TNBC) is associated with poor prognostic and diagnostic outcomes due to the limiting therapeutic strategies, relative to non-TNBC breast cancers. Therefore, the development of targeted therapy for TNBC metastasis remains an urgent issue. In this study, high Carboxyl-terminal modulator protein (CTMP) is significantly associated with recurrence and disease-free survival rate in TNBC patients. Overexpression of CTMP promotes migration and invasion abilities in BT549 cells. Down-regulating of CTMP expression inhibits migration and invasion abilities in MDA-MB-231 cells. In vivo inoculation of high-CTMP cells enhances distant metastasis in mice. The metastasis incidence rate is decreased in mice injected with CTMP-downregulating MDA-MB-231 cells. Gene expression microarray analysis indicates the Akt-dependent pathway is significantly enhanced in CTMP overexpressing cells compared to the parental cells. Blocking Akt activation via Akt inhibitor treatment or co-expression of the dominant-negative form of Akt proteins successfully abolishes the CTMP mediating invasion in TNBC cells. Our findings suggest that CTMP is a potential diagnostic marker for recurrence and poor disease-free survival in TNBC patients. CTMP promotes TNBC metastasis via the Akt-activation-dependent pathway.
AuthorsCheng-Han Lin, Wen-Der Lin, Yun-Chin Huang, Yu-Chia Chen, Zhu-Jun Loh, Luo-Ping Ger, Forn-Chia Lin, Hao-Yi Li, Hui-Chuan Cheng, Kuen-Haur Lee, Michael Hsiao, Pei-Jung Lu
JournalCancer gene therapy (Cancer Gene Ther) Vol. 30 Issue 3 Pg. 404-413 (03 2023) ISSN: 1476-5500 [Electronic] England
PMID36400965 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2022. The Author(s).
Chemical References
  • Carrier Proteins
  • CTMP protein, mouse
  • Palmitoyl-CoA Hydrolase
  • Proto-Oncogene Proteins c-akt
  • THEM4 protein, human
Topics
  • Animals
  • Humans
  • Mice
  • Carrier Proteins (metabolism)
  • Cell Line, Tumor
  • Palmitoyl-CoA Hydrolase (metabolism)
  • Prognosis
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Signal Transduction
  • Triple Negative Breast Neoplasms (metabolism)
  • Female

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: